Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of histone deacetylases in pancreas: Implications for pathogenesis and therapy
E. Klieser, Stefan Swierczynski, Christian Mayr, et al.
World Journal of Gastrointestinal Oncology (2015) Vol. 7, Iss. 12, pp. 473-473
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Lysine acetylation and its role in the pathophysiology of acute pancreatitis
Xiaoqian Li, Xiaolu Li, Jinfeng Zhang, et al.
Inflammation Research (2025) Vol. 74, Iss. 1
Closed Access | Times Cited: 1
Depletion of HDAC1, 7 and 8 by Histone Deacetylase Inhibition Confers Elimination of Pancreatic Cancer Stem Cells in Combination with Gemcitabine
Mao-Hua Cai, Xiaogang Xu, Shili Yan, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 70
Pancreatic Neuroendocrine Tumors: Molecular Mechanisms and Therapeutic Targets
Chandra K. Maharjan, Po Hien Ear, Catherine G. Tran, et al.
Cancers (2021) Vol. 13, Iss. 20, pp. 5117-5117
Open Access | Times Cited: 52
Comprehensive immunohistochemical analysis of histone deacetylases in pancreatic neuroendocrine tumors: HDAC5 as a predictor of poor clinical outcome
E. Klieser, Romana Urbas, Stefan Stättner, et al.
Human Pathology (2017) Vol. 65, pp. 41-52
Closed Access | Times Cited: 56
The trend toward more target therapy in pancreatic ductal adenocarcinoma
Chiara Deiana, Margherita Agostini, Giovanni Brandi, et al.
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 7, pp. 525-565
Open Access | Times Cited: 5
Peptide-targeted, stimuli-responsive polymersomes for delivering a cancer stemness inhibitor to cancer stem cell microtumors
Fataneh Karandish, James Froberg, Pawel P. Borowicz, et al.
Colloids and Surfaces B Biointerfaces (2017) Vol. 163, pp. 225-235
Open Access | Times Cited: 44
Selective Inhibition of Histone Deacetylases 1/2/6 in Combination with Gemcitabine: A Promising Combination for Pancreatic Cancer Therapy
Richard S. Laschanzky, Lisa E. Humphrey, Jihyun Ma, et al.
Cancers (2019) Vol. 11, Iss. 9, pp. 1327-1327
Open Access | Times Cited: 32
Histone deacetylases: A novel class of therapeutic targets for pancreatic cancer
Xuesong Xiang, Pengcheng Li, Wenquan Wang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 1, pp. 188676-188676
Closed Access | Times Cited: 18
Leveraging Epigenetic Alterations in Pancreatic Ductal Adenocarcinoma for Clinical Applications
Jörg Tost, Secil Ak-Aksoy, Daniele Campa, et al.
Seminars in Cancer Biology (2025)
Open Access
Epigenetics of epithelial-to-mesenchymal transition in pancreatic carcinoma
Max M. Träger, Sameer A. Dhayat
International Journal of Cancer (2017) Vol. 141, Iss. 1, pp. 24-32
Open Access | Times Cited: 32
Macrophages: A rising star in immunotherapy for chronic pancreatitis
Hong Xiang, Hao Yu, Qi Zhou, et al.
Pharmacological Research (2022) Vol. 185, pp. 106508-106508
Closed Access | Times Cited: 15
Pancreatic Cancer, A Mis-interpreter of the Epigenetic Language.
Eriko Iguchi, Stephanie L. Safgren, David L. Marks, et al.
PubMed (2016) Vol. 89, Iss. 4, pp. 575-590
Closed Access | Times Cited: 25
Coming in the Air: Hypoxia Meets Epigenetics in Pancreatic Cancer
Claudia Geismann, Alexander Arlt
Cells (2020) Vol. 9, Iss. 11, pp. 2353-2353
Open Access | Times Cited: 22
Role of HDAC6 and Its Selective Inhibitors in Gastrointestinal Cancer
Bingyi Zhou, Deliang Liu, Yuyong Tan
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 20
Clinical Applications of Classical and Novel Biological Markers of Pancreatic Cancer
Leonel Pekarek, Oscar Fraile‐Martínez, Cielo García‐Montero, et al.
Cancers (2022) Vol. 14, Iss. 8, pp. 1866-1866
Open Access | Times Cited: 14
Epigenetics in Pancreatic Ductal Adenocarcinoma: Impact on Biology and Utilization in Diagnostics and Treatment
Asmaa Elrakaybi, Dietrich Alexander Ruess, Michael Lübbert, et al.
Cancers (2022) Vol. 14, Iss. 23, pp. 5926-5926
Open Access | Times Cited: 13
HDAC-Linked “Proliferative” miRNA Expression Pattern in Pancreatic Neuroendocrine Tumors
E. Klieser, Romana Urbas, Stefan Swierczynski, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 9, pp. 2781-2781
Open Access | Times Cited: 23
Association of H3K79 monomethylation (an epigenetic signature) with arsenic-induced skin lesions
Pritha Bhattacharjee, Somnath Paul, Sandip Bhattacharjee, et al.
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis (2017) Vol. 807, pp. 1-9
Closed Access | Times Cited: 22
Epigenetic Regulation in Gastroenteropancreatic Neuroendocrine Tumors
Judy S. Crabtree
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12
Connectivity mapping-based identification of pharmacological inhibitor targeting HDAC6 in aggressive pancreatic ductal adenocarcinoma
Pranita Atri, Ashu Shah, Kavumpurathu Raman Thankappan, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 2
The Effect of Intratumor Heterogeneity in Pancreatic Ductal Adenocarcinoma Progression and Treatment
Othman Saleh, Hani Shihadeh, Ahmad Yousef, et al.
Pancreas (2024) Vol. 53, Iss. 5, pp. e450-e465
Closed Access | Times Cited: 2
The histone deacetylase inhibitor M344 as a multifaceted therapy for pancreatic cancer
Shelby M. Knoche, Gabrielle L. Brumfield, Benjamin T. Goetz, et al.
PLoS ONE (2022) Vol. 17, Iss. 9, pp. e0273518-e0273518
Open Access | Times Cited: 10
Carbohydrate Antigen 19-9 Is a Prognostic Factor Which Correlates With HDAC1 and HIF-1α for Intrahepatic Cholangiocarcinoma
S Ohta, Yuji Morine, Satoru Imura, et al.
Anticancer Research (2019) Vol. 39, Iss. 11, pp. 6025-6033
Open Access | Times Cited: 11
Epigenetic Disruption of Histone Deacetylase-2 Accelerated Apoptotic Signaling and Retarded Malignancy in Gastric Cells
Sayedeh Azimeh Hosseini, Mahdi Ghatrehsamani, Hajar Yaghoobi, et al.
Epigenomics (2024) Vol. 16, Iss. 5, pp. 277-292
Closed Access | Times Cited: 1
Boronate-based bioactive compounds activated by peroxynitrite and hydrogen peroxide
Monika Rola, Jacek Zielonka, Renata Smulik-Izydorczyk, et al.
Redox Biochemistry and Chemistry (2024) Vol. 10, pp. 100040-100040
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top